Keyphrases
Glioma
100%
Magnetic Resonance Spectroscopy
100%
Magnetic Resonance
100%
Isocitrate Dehydrogenase 1 (IDH1)
100%
2-Hydroxyglutarate (2-HG)
100%
New Frontiers
100%
Neurodiagnostics
100%
Isocitrate Dehydrogenase mutation
50%
New Biomarkers
25%
Clinical Practice
25%
Immunohistochemistry
25%
Brain Tumor
25%
Response to Treatment
25%
Prognostic Indicator
25%
Tumor Progression
25%
Improved Survival
25%
Neuroimaging
25%
Genome Sequencing
25%
Survival Rate
25%
Surgical Specimen
25%
Mutation Status
25%
Diagnostic Information
25%
Oncologic
25%
Histological Analysis
25%
Prognostic Information
25%
Australia
25%
Spectroscopic Techniques
25%
Oncometabolite
25%
Isocitrate Dehydrogenase Gene
25%
Mutation Detection
25%
Information for Patients
25%
Diffuse Glioma
25%
Diagnostic Indicator
25%
Status Information
25%
Integrated Genomics
25%
Predictive Role
25%
Therapeutic Indicators
25%
Medicine and Dentistry
Ganglioglioma
100%
Nuclear Magnetic Resonance
100%
Isocitrate Dehydrogenase
100%
Nuclear Magnetic Resonance Spectroscopy
80%
2 Hydroxyglutaric Acid
80%
Diagnosis
40%
Biological Marker
20%
Immunohistochemistry
20%
Brain Tumor
20%
Sensitivity and Specificity
20%
Survival Rate
20%
Tumor Progression
20%
Spectroscopy Technique
20%
Neuroscience
Isocitrate Dehydrogenase
100%
Nuclear Magnetic Resonance Spectroscopy
80%
In Vivo
20%
Immunohistochemistry
20%
Brain Tumor
20%
IDH2
20%